Lv3
370 积分 2023-09-08 加入
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
15天前
已完结
LEAP-002 - Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
1年前
已完结
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
1年前
已完结
Cascade Catalytically Released Nitric Oxide‐Driven Nanomotor with Enhanced Penetration for Antibiofilm
皖公网安备34019202002308
